HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition.

Abstract
Rapamycin, a natural product inhibitor of the Raptor-mammalian target of rapamycin complex (mTORC1), is known to induce Protein kinase B (Akt/PKB) Ser-473 phosphorylation in a subset of human cancer cell lines through inactivation of S6K1, stabilization of insulin receptor substrate (IRS)-1, and increased signaling through the insulin/insulin-like growth factor-I/phosphatidylinositol 3-kinase (PI3K) axis. We report that A-443654, a potent small-molecule inhibitor of Akt serine/threonine kinases, induces Akt Ser-473 phosphorylation in all human cancer cell lines tested, including PTEN- and TSC2-deficient lines. This phenomenon is dose-dependent, manifests coincident with Akt inhibition and likely represents an alternative, rapid-feedback pathway that can be functionally dissociated from mTORC1 inhibition. Experiments performed in TSC2-/- cells indicate that TSC2 and IRS-1 cooperate with, but are dispensable for, A-443654-mediated Akt phosphorylation. This feedback event does require PI3K activity, however, as it can be inhibited by LY294002 or wortmannin. Small interfering RNA-mediated knockdown of mTOR or Rictor, components of the rapamycin-insensitive mTORC2 complex, but not the mTORC1 component Raptor, also inhibited Akt Ser-473 phosphorylation induced by A-443654. Our data thus indicate that Akt phosphorylation and activity are coupled in a manner not previously appreciated and provide a novel mode of Akt regulation that is distinct from the previously described rapamycin-induced IRS-1 stabilization mechanism.
AuthorsE K-H Han, J D Leverson, T McGonigal, O J Shah, K W Woods, T Hunter, V L Giranda, Y Luo
JournalOncogene (Oncogene) Vol. 26 Issue 38 Pg. 5655-61 (Aug 16 2007) ISSN: 0950-9232 [Print] England
PMID17334390 (Publication Type: Journal Article)
Chemical References
  • A 443654
  • Chromones
  • Enzyme Inhibitors
  • Indazoles
  • Indoles
  • Morpholines
  • Multiprotein Complexes
  • Phosphoinositide-3 Kinase Inhibitors
  • Proteins
  • RNA, Small Interfering
  • TSC2 protein, human
  • Transcription Factors
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Serine
  • Mechanistic Target of Rapamycin Complex 1
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
Topics
  • Cell Line, Tumor
  • Chromones (pharmacology)
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors (pharmacology)
  • Humans
  • Immunoblotting
  • Indazoles (pharmacology)
  • Indoles (pharmacology)
  • Mechanistic Target of Rapamycin Complex 1
  • Morpholines (pharmacology)
  • Multiprotein Complexes
  • Mutation
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation (drug effects)
  • Proteins
  • Proto-Oncogene Proteins c-akt (antagonists & inhibitors, metabolism)
  • RNA, Small Interfering (genetics)
  • Serine (metabolism)
  • TOR Serine-Threonine Kinases
  • Time Factors
  • Transcription Factors (genetics, metabolism)
  • Transfection
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: